70
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Green polymer altered in-situ gel oral liquid sustainable release preparation of vildagliptin suitable for dysphagic diabetic patients: assessment in-vitro & in-vivo

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 585-594 | Received 17 Feb 2023, Accepted 06 Jun 2023, Published online: 21 Jun 2023

References

  • Attebäck M, Hedin B, Mattsson S. 2022. Formulation optimization of extemporaneous oral liquids containing naloxone and propranolol for pediatric use. Sci Pharm. 90(1):15. doi: 10.3390/scipharm90010015.
  • Awasthi R, Kulkarni GT, Ramana MV, de Jesus Andreoli Pinto T, Kikuchi IS, Molim Ghisleni DD, de Souza Braga M, De Bank P, Dua K. 2017. Dual crosslinked pectin-alginate network as sustained release hydrophilic matrix for repaglinide. Int J Biol Macromol. 97:721–732. doi: 10.1016/j.ijbiomac.2017.01.050.
  • Bashir R, Majeed A, Ali T, Farooq S, Khan NA. 2019. Floating Oral In-Situ Gel: a Review. J Drug Delivery Ther. 9(2):442–448. doi: 10.22270/jddt.v9i2.2372.
  • Bhatta RG, Rudragangaiah S, Birur Kotappa SB. 2019. Formulation, optimization and evaluation of in-situ gelling liquid oral formulation of a novel antidiabetic drug: canagliflozin. IJPER. 53(2s):s121–s128. doi: 10.5530/ijper.53.2s.56.
  • Cichero JA. 2013. Thickening agents used for dysphagia management: effect on the bioavailability of water, medication, and feelings of satiety. Nutr J. 12:54. doi: 10.1186/1475-2891-12-54.
  • Dewan I, Islam S, Rana MS. 2015. Characterization and compatibility studies of different rate retardant polymer loaded microspheres by solvent evaporation technique: in vitro in vivo study of vildagliptin as a model drug. J Drug Deliv. 2015:496807. doi: 10.1155/2015/496807.
  • Draget KI, Skjåk-Bræk G, Stokke BT. 2006. Similarities and differences between alginic acid gels and ionically crosslinked alginate gels. Food. Hydrocoll. 20(2-3):170–175. doi: 10.1016/j.foodhyd.2004.03.009.
  • Easson M, Villalpando A, Condon BD. 2017. Absorbent properties of carboxymethylated fiber, hydroentangled nonwoven and regenerated cellulose: a comparative study. J. Eng. Fibers Fabr. 12(4):155892501701200. doi: 10.1177/155892501701200408.
  • El Maghraby GM, Elsisi AE, Elmeshad GA. 2015. Development of liquid oral sustained release formulations of nateglinide: in vitro and in vivo evaluation. J Drug Delivery Sci Technol. 29:70–77. doi: 10.1016/j.jddst.2015.06.011.
  • El Maghraby GM, Elzayat EM, Alanazi FK. 2012. Development of modified in situ gelling oral liquid sustained release formulation of dextromethorphan. Drug Dev Ind Pharm. 38(8):971–978. doi: 10.3109/03639045.2011.634811.
  • Elkarray SM, Farid RM, Abd-Alhaseeb MM, Omran GA, Habib DA. 2022. Intranasal repaglinide-solid lipid nanoparticles integrated in situ gel outperform conventional oral route in hypoglycemic activity. J Drug Delivery Sci Technol. 68:103086. doi: 10.1016/j.jddst.2021.103086.
  • El-Masry SM, Helmy SA. 2020. Hydrogel-based matrices for controlled drug delivery of etamsylate: prediction of in-vivo plasma profiles. Saudi Pharm J. 28(12):1704–1718. doi: 10.1016/j.jsps.2020.10.016.
  • Federiuk IF, Casey HM, Quinn MJ, Wood MD, Ward KW. 2004. Induction of type-1 diabetes mellitus in laboratory rats by use of alloxan: route of administration, pitfalls, and insulin treatment. Compar Med. 54(3):252–257.
  • Fu S, Thacker A, Sperger DM, Boni RL, Buckner IS, Velankar S, Munson EJ, Block LH. 2011. Relevance of rheological properties of sodium alginate in solution to calcium alginate gel properties. AAPS PharmSciTech. 12(2):453–460. doi: 10.1208/s12249-011-9587-0.
  • George NS, Rangan V, Geng Z, Khan F, Kichler A, Gabbard S, Ganocy S, Fass R. 2017. Distribution of esophageal motor disorders in diabetic patients with dysphagia. J Clin Gastroenterol. 51(10):890–895. doi: 10.1097/MCG.0000000000000894.
  • Higuchi T. 1963. Mechanism of sustained‐action medication. J Pharm Sci. 52:1145–1149. doi: 10.1002/jps.2600521210.
  • Holloway RH, Tippett D, Horowitz M, Maddox AF, Moten J, Russo A. 1999. Relationship between esophageal motility and transit in patients with type I diabetes mellitus. Am J Gastroenterol. 94(11):3150–3157. doi: 10.1111/j.1572-0241.1999.01508.x.
  • Ighodaro OM, Adeosun AM, Akinloye OA. 2017. Alloxan-induced diabetes, a common model for evaluating the glycemic-control potential of therapeutic compounds and plants extracts in experimental studies. Medicina. 53(6):365–374. doi: 10.1016/j.medici.2018.02.001.
  • Itoh K, Hatakeyama T, Shimoyama T, Miyazaki S, D'Emanuele A, Attwood D. 2011. In situ gelling formulation based on methylcellulose/pectin system for oral-sustained drug delivery to dysphagic patients. Drug Dev Ind Pharm. 37(7):790–797. doi: 10.3109/03639045.2010.541465.
  • Itoh K, Kubo W, Fujiwara M, Watanabe H, Miyazaki S, Attwood D. 2006. The influence of gastric acidity and taste masking agent on in situ gelling pectin formulations for oral sustained delivery of acetaminophen. Biol Pharm Bull. 29(2):343–347. doi: 10.1248/bpb.29.343.
  • Itoh K, Yahaba M, Takahashi A, Tsuruya R, Miyazaki S, Dairaku M, Togashi M, Mikami R, Attwood D. 2008. In situ gelling xyloglucan/pectin formulations for oral sustained drug delivery. Int J Pharm. 22; 356(1-2):95–101. doi: 10.1016/j.ijpharm.2007.12.049.
  • Jacob S, Mathew A, Shyma MS. 2020. oral in-situ gelling system. J. Pharm. Sci. & Res. 12(8):1056–1061.
  • Jain D, Bar-Shalom D. 2014. Alginate drug delivery systems: application in the context of pharmaceutical and biomedical research. Drug Dev Ind Pharm. 40(12):1576–1584. doi: 10.3109/03639045.2014.917657.
  • Javanbakht S, Shaabani A. 2019. Carboxymethyl cellulose-based oral delivery systems. Int J Biol Macromol. 133:21–29. doi: 10.1016/j.ijbiomac.2019.04.079.
  • Karkos PD, Papouliakos S, Karkos CD, Theochari EG. 2009. Current evaluation of the dysphagic patient. Hippokratia. 13(3):141–146.
  • Kassem AA, Abd El-Alim SH, Basha M, Salama A. 2017. Phospholipid complex enriched micelles: a novel drug delivery approach for promoting the anti-diabetic effect of repaglinide. Eur J Pharm Sci. 99:75–84. doi: 10.1016/j.ejps.2016.12.005.
  • Kelly J, D'Cruz G, Wright D. 2009. A qualitative study of the problems surrounding medicine administration to patients with dysphagia. Dysphagia. 24(1):49–56. doi: 10.1007/s00455-008-9170-3.
  • Kelly J, D'Cruz G, Wright D. 2010. Patients with dysphagia: experiences of taking medication. J Adv Nurs. 66(1):82–91. doi: 10.1111/j.1365-2648.2009.05145.x.
  • Khan KA. 1975. The concept of dissolution efficiency. J Pharm Pharmacol. 27(1):48–49. doi: 10.1111/j.2042-7158.1975.tb09378.x.
  • Kubo W, Miyazaki S, Attwood D. 2003. Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations. Int J Pharm. 258(1-2):55–64. doi: 10.1016/s0378-5173(03)00163-7.
  • Lauster CD, McKaveney TP, Muench SV. 2007. Vildagliptin: a novel oral therapy for Type 2 diabetes mellitus. Am J Health Syst Pharm. 64(12):1265–1273. doi: 10.2146/ajhp060564.
  • Layek B, Mandal S. 2020. Natural polysaccharides for controlled delivery of oral therapeutics: a recent update. Carbohydr Polym. 230:115617. doi: 10.1016/j.carbpol.2019.115617.
  • Lee KY, Mooney DJ. 2012. Alginate: properties and biomedical applications. Prog Polym Sci. 37(1):106–126. doi: 10.1016/j.progpolymsci.2011.06.003.
  • Lenzen S, Munday R. 1991. Thiol-group reactivity, hydrophilicity and stability of alloxan, its reduction products, and its N-methyl derivatives and a comparison with ninhydrin. Biochem Pharmacol. 42(7):1385–1391. doi: 10.1016/0006-2952(91)90449-f.
  • Miehle E, Bader-Mittermaier S, Schweiggert-Weisz U, Hauner H, Eisner P. 2021. Effect of physicochemical properties of carboxymethyl cellulose on diffusion of glucose. Nutrients. 13(5):1398. doi: 10.3390/nu13051398.
  • Miyazaki S, Aoyama H, Kawasaki N, Kubo W, Attwood D. 1999. In situ-gelling gellan formulations as vehicles for oral drug delivery. J Control Release. 60(2-3):287–295. doi: 10.1016/s0168-3659(99)00084-x.
  • Miyazaki S, Kubo W, Attwood D. 2000. Oral sustained delivery of theophylline using in-situ gelation of sodium alginate. J Control Release. 67(2-3):275–280. doi: 10.1016/s0168-3659(00)00214-5.
  • Molaei MA, Osouli-Bostanabad K, Adibkia K, Shokri J, Asnaashari S, Javadzadeh Y. 2018. Enhancement of ketoconazole dissolution rate by the liquisolid technique. Acta Pharm. 168(3):325–336. doi: 10.2478/acph-2018-0025.
  • National Dysphagia Diet Task Force. 2002. National Dysphagia Diet: standardization for Optimal Care. Chicago, IL: American Dietetic Association.
  • Pourjavadi A, Barzegar S, Mahdavinia GR. 2006. MBA-crosslinked Na-Alg/CMC as smart full-polysaccharide superabsorbent hydrogels. Carbohydr Polym. 66(3):386–395. doi: 10.1016/j.carbpol.2006.03.013.
  • Qinna NA, Badwan AA. 2015. Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats. Drug Des Devel Ther. 9:2515–2525. doi: 10.2147/DDDT.S79885.
  • Refaat R, Sakr A, Salama M, El Sarha A. 2016. Combination of vildagliptin and pioglitazone in experimental type 2 diabetes in male rats. Drug Dev Res. 77(6):300–309. doi: 10.1002/ddr.21324.
  • Riyajan S-A, Nuim J. 2013. Interaction of green polymer blend of modified sodium alginate and carboxylmethyl cellulose encapsulation of turmeric extract. Internatl J Polym Sci. 2013:1–10. doi: 10.1155/2013/364253.
  • Rosilio V, Albrecht G, Baszkin A, Merle L. 2000. Surface properties of hydrophobically modified carboxymethylcellulose derivatives. Colloids Surf B. 19(2):163–172. doi: 10.1016/S0927-7765(00)00151-X.
  • Shaikh HK, Kshirsagar RV, Patil SG. 2015. Mathematical models for drug release characterization: a review. World J Pharm Pharm Sci. 4:324–338.
  • Shimoyama T, Itoh K, Kobayashi M, Miyazaki S, D'Emanuele A, Attwood D. 2012. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients. Drug Dev Ind Pharm. 38(8):952–960. doi: 10.3109/03639045.2011.634809.
  • Ullah F, Othman MB, Javed F, Ahmad Z, Md Akil H. 2015. Classification, processing and application of hydrogels: a review. Mater Sci Eng C Mater Biol Appl. 57:414–433. 1doi: 10.1016/j.msec.2015.07.053.
  • Wan T, Zhou Z, Huang R, Zou C, Xu M, Cheng W, Li R. 2014. Synthesis and swelling properties of microcrystal muscovite composite superabsorbent. Appl. Clay Sci. 101:199–204. doi: 10.1016/j.clay.2014.07.035.
  • Wang Y, Wang W, Shi X, Wang A. 2013. Enhanced swelling and responsive properties of an alginate-based superabsorbent hydrogel by sodium p-styrenesulfonate and attapulgite nanorods. Polym. Bull. 70(4):1181–1193. doi: 10.1007/s00289-012-0901-0.
  • Wilkinson JM, Codipilly DC, Wilfahrt RP. 2021. Dysphagia: evaluation and collaborative management. Am Fam Physician. 103(2):97–106.
  • Yadav VK, Kumar B, Prajapati SK, Shafaat K. 2011. Design and evaluation of mucoadhesive microspheres of repaglinide for oral controlled release. Int. J. Drug Deliv. 1:357–370.
  • Yang XH, Zhu WL. 2007. Viscosity properties of sodium carboxymethylcellulose solutions. Cellulose. 14(5):409–417. doi: 10.1007/s10570-007-9137-9.
  • Zheng J, Zeng R, Zhang F, Kan J. 2019. Effects of sodium carboxymethyl cellulose on rheological properties and gelation behaviors of sodium alginate induced by calcium ions. LWT - Food Science and Technology. 103:131–138. doi: 10.1016/j.lwt.2018.12.081.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.